Clinical trial
Cetirizine Placebo Controlled Study For Perennial Allergic Rhinitis
NCT00490204 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00490204 |
|---|---|
| Title | Cetirizine Placebo Controlled Study For Perennial Allergic Rhinitis |
| Official title | A Randomized, Double Blind, Placebo Controlled Study for Evaluation of the Efficacy and Safety of Cetirizine Dry Syrup (CTZ DS) (2.5 mg or 5 mg Twice a Day) in Children (2 Years of Age or Older But Under 15 Years Old) Suffering From Perennial Allergic Rhinitis. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rhinitis, Allergic, Perennial |
| Intervention type | Drug |
| Interventions | Cetirizine |
| Enrollment | 239 |
| Start date | Jul 27, 2007 |
| Primary completion | Oct 3, 2007 |
| Completion | Oct 3, 2007 |
| First posted | Jun 22, 2007 |
| Last update posted | Aug 29, 2017 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: